South Africa's Aspen Pharmacare may be forced to shut down its production of Johnson & Johnson's single-dose COVID-19 vaccines if African countries do not place orders. According to a company executive, Aspen Pharmacare has not received any orders since the company signed initial terms for a licensing deal with Johnson & Johnson late last year.
Subscribe to us on YouTube: http://ow.ly/Zvqj30aIsgY
Follow us on:
- South Africa
- Africa, News, south africa, Pharmacare